PBS approval for new once-a-day diabetes medications 9 December 2014 New once-a-day fixed-dose medications for people with type 2 diabetes have been approved for inclusion on the Pharmaceutical Benefits Scheme (PBS). The two new treatments are linagliptin with metformin (sold as Trajenta Duo), and saxagliptin with metformin (sold as Kombiglyze). Federal Health Minister Peter Dutton said that while people with type 2 diabetes already have access to the individual medications through the PBS, some need to use a combination of medicines to treat their diabetes. “With the combination dose now listed on the PBS, these patients will save up to $36.90 every time they get a script filled because they will only have to buy one fixed dose medicine instead of two,†Mr Dutton said. The new treatments are available via prescription. For more information, please contact your doctor or endocrinologist.
Partners 28 November 2023 Dexcom G6 Continuous Glucose Monitoring (CGM) – For people living with Type 1, Type 2 and Gestational Diabetes*Trial now for only $32.10!† Advertisement ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult... Continue Reading
Partners 28 November 2023 Glucose readings every minute for you† and your loved ones* Advertisement The latest version of the FreeStyle LibreLink app† now allows you to receive continuous glucose readings on your phone,... Continue Reading
Media releases 24 November 2023 New vitamin C diabetes research announced Deakin University’s Professor Glenn Wadley is a recipient of one of this year’s Diabetes Australia Research Program (DARP) grants to study the efficacy of vitamin C in the treatment of foot ulcers in people living with diabetes, which can lead to amputations. Continue Reading
